These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 9457719

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Medulloblastoma. Period of risk reviewed.
    Latchaw JP, Hahn JF, Moylan DJ, Humphries R, Mealey J.
    Cancer; 1985 Jan 01; 55(1):186-9. PubMed ID: 3965079
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Survival and prognostic factors in a series of adults with medulloblastomas.
    Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.
    J Neurosurg; 2009 Sep 01; 111(3):478-87. PubMed ID: 19231932
    [Abstract] [Full Text] [Related]

  • 6. Medulloblastoma and Collins' law: a critical review of the concept of a period of risk for tumor recurrence and patient survival.
    Brown WD, Tavaré CJ, Sobel EL, Gilles FH.
    Neurosurgery; 1995 Apr 01; 36(4):691-7. PubMed ID: 7596498
    [Abstract] [Full Text] [Related]

  • 7. Late recurrence of primitive neuroectodermal tumor/medulloblastoma.
    Lefkowitz IB, Packer RJ, Ryan SG, Shah N, Alavi J, Rorke LB, Sutton LN, Schut L.
    Cancer; 1988 Aug 15; 62(4):826-30. PubMed ID: 2840194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Local control in non-metastatic medulloblastoma.
    Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB, Indelicato DJ.
    Acta Oncol; 2014 Sep 15; 53(9):1151-7. PubMed ID: 24991891
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
    Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ.
    Lancet Oncol; 2006 Oct 15; 7(10):813-20. PubMed ID: 17012043
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
    Roldán G, Brasher P, Vecil G, Senger D, Rewcastle B, Cairncross G, Forsyth P, Hamilton M.
    Can J Neurol Sci; 2008 May 15; 35(2):210-5. PubMed ID: 18574936
    [Abstract] [Full Text] [Related]

  • 16. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
    Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P.
    Acta Oncol; 2017 May 15; 56(5):698-705. PubMed ID: 28325133
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.